Xu B - Search Results

1

Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China.

Huang J, Mo H, Zhang W, Chen X, Qu D, Wang X, Wu D, Wang X, Lan B, Yang B, Wang P, Zhang B, Yang Q, Jiao Y, Xu B. Huang J, et al. Among authors: xu b. Cancer. 2019 Mar 1;125(5):742-749. doi: 10.1002/cncr.31855. Epub 2018 Dec 3. Cancer. 2019. PMID: 30508306 Free article. Clinical Trial.

2

[Inflammatory breast cancer: 38 cases clinical report].

Huang J, Zhang P, Liu P, Ou GF, Wang ZP, Xu BH. Huang J, et al. Ai Zheng. 2002 Aug;21(8):888-91. Ai Zheng. 2002. PMID: 12478900 Chinese.

3

[Oral combination chemotherapy of 5'-deoxy-5-fluorouridine (furtulon) and cyclophosphamide for advanced breast cancer].

Xu BH, Zhang YJ, Zheng X, Wu Q, Wu XT. Xu BH, et al. Zhonghua Zhong Liu Za Zhi. 2003 May;25(3):282-4. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 12839696 Chinese.

4

[Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer].

Wang ZH, Miao XP, Tan W, Zhang XR, Xu BH, Lin DX. Wang ZH, et al. Ai Zheng. 2004 Aug;23(8):865-8. Ai Zheng. 2004. PMID: 15301704 Chinese.

5

[Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy].

Yuan P, Miao XP, Zhang XM, Wang ZH, Tan W, Zhang XR, Sun Y, Xu BH, Lin DX. Yuan P, et al. Ai Zheng. 2005 Dec;24(12):1510-3. Ai Zheng. 2005. PMID: 16351803 Chinese.

6

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.

Ma F, Sun T, Shi Y, Yu D, Tan W, Yang M, Wu C, Chu D, Sun Y, Xu B, Lin D. Ma F, et al. Among authors: xu b. Lung Cancer. 2009 Oct;66(1):114-9. doi: 10.1016/j.lungcan.2008.12.025. Epub 2009 Feb 6. Lung Cancer. 2009. PMID: 19201048

7

Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment.

Wang J, Fan Y, Xu B. Wang J, et al. Among authors: xu b. Cancer Chemother Pharmacol. 2010 Aug;66(3):597-603. doi: 10.1007/s00280-010-1362-5. Epub 2010 May 21. Cancer Chemother Pharmacol. 2010. PMID: 20490795 Clinical Trial.

8

No association between XRCC1 polymorphisms and survival in non-small-cell lung cancer patients treated with platinum-based chemotherapy.

Yuan P, Liu L, Wu C, Zhong R, Yu D, Wu J, Xu Y, Nie S, Miao X, Sun Y, Xu B, Lin D. Yuan P, et al. Among authors: xu b, xu y. Cancer Biol Ther. 2010 Nov 1;10(9):854-9. doi: 10.4161/cbt.10.9.13238. Epub 2010 Nov 1. Cancer Biol Ther. 2010. PMID: 20814250 Free article.

9

Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.

Xu B, Jiang Z, Shao Z, Wang J, Feng J, Song S, Chen Z, Gu K, Yu S, Zhang Y, Wang C, Zhang F, Yang J. Xu B, et al. Cancer Chemother Pharmacol. 2011 Jan;67(1):223-30. doi: 10.1007/s00280-010-1483-x. Epub 2010 Oct 12. Cancer Chemother Pharmacol. 2011. PMID: 20938664 Clinical Trial.

10

Genome-wide interrogation identifies YAP1 variants associated with survival of small-cell lung cancer patients.

Wu C, Xu B, Yuan P, Miao X, Liu Y, Guan Y, Yu D, Xu J, Zhang T, Shen H, Wu T, Lin D. Wu C, et al. Among authors: xu b, xu j. Cancer Res. 2010 Dec 1;70(23):9721-9. doi: 10.1158/0008-5472.CAN-10-1493. Epub 2010 Nov 30. Cancer Res. 2010. PMID: 21118971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,000 results

Search Page

Filters